Related Experiment Video
Updated: May 5, 2026

Autologous Endothelial Progenitor Cell-Seeding Technology and Biocompatibility Testing For Cardiovascular Devices in Large Animal Model
Published on: September 9, 2011
Treating deep venous insufficiency with a novel implantable device
Mark Awad1, Nicholas Schaper2, Saideep Bose1,2
1Saint Louis University Division of Vascular and Endovascular Surgery, St. Louis, MO.
A new VenoValve device offers hope for chronic venous insufficiency (CVI) patients who have not responded to other treatments. This bioprosthetic valve showed success in a patient with advanced CVI and leg wounds.
Area of Science:
- Vascular Surgery
- Biomedical Engineering
- Regenerative Medicine
Background:
- Chronic venous insufficiency (CVI) is a growing global health concern.
- Existing treatments for CVI have limitations, particularly for advanced cases.
- There is a need for novel therapeutic options for CVI patients with treatment failure.
Observation:
- A novel bioprosthetic device, the VenoValve, was investigated for CVI treatment.
- The VenoValve was implanted in the left femoral vein of a 72-year-old male patient with bilateral CVI and leg wounds.
- The surgical approach was an open anterior technique.
Findings:
- The patient experienced no postoperative complications following VenoValve implantation.
- The VenoValve remained patent at the 6-month follow-up.
- The treatment demonstrated positive outcomes for advanced CVI.
Implications:
- The VenoValve shows potential as a viable treatment for advanced chronic venous insufficiency.
- This device may offer a new therapeutic avenue for patients with CVI who have failed previous treatments.
- Further research and clinical trials are warranted to establish the long-term efficacy and safety of the VenoValve.
Related Concept Videos
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management

